Literature DB >> 12209501

Pulmonary hypertension in autoimmune rheumatic diseases: where are we now?

M Magliano1, D A Isenberg, J Hillson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12209501     DOI： 10.1002/art.10442

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  Pulmonary arterial hypertension.

Authors:  Aydin Uzunpinar; Mehmet Cilingiroglu
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

2.  Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.

Authors:  Judit Végh; Györgyike Soós; István Csipõ; Nóra Demeter; Thomas Ben; Balázs Dezsõ; Margit Zeher; Katalin Dévényi; János Gaál; Gyula Szegedi; Edit Bodolay
Journal:  Rheumatol Int       Date:  2005-07-12       Impact factor: 2.631

Review 3.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

4.  Primary pulmonary arterial hypertension and autoimmune polyendocrine syndrome in a pediatric patient.

Authors:  Mohammed H Alghamdi; Michelle Steinraths; Constadina Panagiotopoulos; James E Potts; George G S Sandor
Journal:  Pediatr Cardiol       Date:  2010-04-22       Impact factor: 1.655

5.  Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

Authors:  Ayse Cefle; Murat Inanc; Mehmet Sayarlioglu; Sevil Kamali; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

Review 6.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

7.  Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension.

Authors:  Silvia Ulrich; Mark R Nicolls; Laima Taraseviciene; Rudolf Speich; Norbert Voelkel
Journal:  Respiration       Date:  2007-11-20       Impact factor: 3.580

8.  Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.

Authors:  Uma Kumar; Gokhale Sankalp; Sankalp S Gokhle; V Sreenivas; Satbir Kaur; Durgaprasanna Misra
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

9.  Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.

Authors:  Paola Caramaschi; Domenico Biasi; Marcello Ferrari; Alessandro Volpe; Nicola Martinelli; Antonio Carletto; Paola Dal Forno; Lisa Maria Bambara
Journal:  Rheumatol Int       Date:  2004-02-13       Impact factor: 2.631

10.  Pulmonary arterial hypertension in primary amyloidosis.

Authors:  Meghan M Cirulis; Lyska L Emerson; David A Bull; Nathan Hatton; Jose Nativi-Nicolai; Gerhard C Hildebrandt; John J Ryan
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.